Document is current
Any future updates will be listed below
-
Authors
Wang, Xueying
Wu, Feifei
Zhang, Jinfan
Song, Xinyu
Liu, Pan
Liu, Ziqin
Wang, Junling
Zhang, Yuanchao
Grecucci, Alessandro
Yi, Xiaoping
Chen, Bihong T.
-
Funding
Funding for this research was provided by:
the Scientific Research Program of FuRong Laboratory (2024PT5109)
National Key R&D Program of China (2021YFA0805202)
Fundamental Research Funds for Central Universities of the Central South University (2024ZZTS0954)
Scientific research project of Xiangnan University (2020XJ88)
Natural Science Foundation of Hunan Province (2023JJ50382)
Scientific research project of Hunan Provincial Health Commission (D202303077714)
the Joint Research Fund of Chongqing University Three Gorges Hospital-Peking University Human Dajiaweikang Pharmaceutical Industry Co.,Ltd. (IIT2025-00111)
- License Information
-
More Information
Article History
Received: 16 January 2026
Accepted: 25 March 2026
First Online: 16 April 2026
Declarations
:
: This research was approved by the Ethics Committee and Institutional Review Board of Xiangya hospital, Central South University (IRB No. 202103191). Informed consent was obtained from all individual participants included in the study.
: The authors declare no conflicts of interest.
